Stati Uniti - inglese - NLM (National Library of Medicine)

gm holdings co., ltd - ceramide 3 (unii: 4370df050b) (ceramide 3 - unii:4370df050b) - ceramide 3 0.05 in 200 ml

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - borax 12%; glycerol 88% - oral solution - 12 % - active: borax 12% glycerol 88%

Stati Uniti - inglese - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - deferoxamine mesylate (unii: v9tko7eo6k) (deferoxamine - unii:j06y7mxw4d) - deferoxamine mesylate 500 mg - desferal is indicated as an adjunct to standard measures for the treatment of acute iron intoxication. desferal is indicated for the treatment of transfusional iron overload in patients with chronic anemia. desferal is not indicated for the treatment of primary hemochromatosis (since phlebotomy is the method of choice for removing excess iron in this disorder). desferal is contraindicated in patients with: - a history of a hypersensitivity reaction to deferoxamine or any of its inactive ingredients [see description (11)] . reactions have included anaphylaxis [see warnings and precautions (5.1)] . - severe renal disease or anuria since the drug and the iron chelate are excreted primarily by the kidney [see warnings and precautions (5.3)] . risk summary there are no available data on desferal use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriages or adverse maternal or fetal outcomes. in animal reproduction studies subcutaneous administration of deferoxamine to pregnan

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - toceranib - oral tablet - toceranib enzyme active 10.0 mg/tb - anti-neoplastic agent - dog | bitch | castrate | puppy - patnaik grade ii or iii recurrent | cutaneous mast cell tumours | node involvement in dogs | with or without regional lymph

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - toceranib - oral tablet - toceranib enzyme active 15.0 mg/tb - anti-neoplastic agent - dog | bitch | castrate | puppy - patnaik grade ii or iii recurrent | cutaneous mast cell tumours | node involvement in dogs | with or without regional lymph

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - toceranib - oral tablet - toceranib enzyme active 50.0 mg/tb - anti-neoplastic agent - dog | bitch | castrate | puppy - patnaik grade ii or iii recurrent | cutaneous mast cell tumours | node involvement in dogs | with or without regional lymph

Israele - inglese - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - anidulafungin - powder for concentrate for solution for infusion - anidulafungin 100 mg/vial - anidulafungin - anidulafungin - treatment of invasive candidiasis in adults and paediatric patients aged 1 month to < 18 years

Australia - inglese - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - anidulafungin, quantity: 100 mg - injection, powder for - excipient ingredients: tartaric acid; mannitol; fructose; polysorbate 80 - treatment of invasive candidiasis, including candidaemia in adult and in paediatric patients one month and older (see section 5.1)

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

animal control technologies (australia) pty ltd - sodium fluoroacetate - bait - sodium fluoroacetate mineral-fluorine active 0.3 g/kg - vertebrate poison - above ground bait | aerial baiting - feral pig

Uganda - inglese - National Drug Authority

sev pharmaceuticals limited; sev pharmaceuticals limited - glycerine+borax - oral liquid ordinary liquids - 12%w/v